These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2508582)

  • 1. [Initial resistance to streptomycin, isoniazid, thiacetazone, rifampicin and ethambutol in bacilliferous tuberculosis in Maniema, Zaire].
    De Caluwé P; Everaerts MC; Dufour B; wa Tshalumba M
    Ann Soc Belg Med Trop; 1989 Jun; 69(2):143-7. PubMed ID: 2508582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[Potential and limitations of the long-term treatment of bacilliferous tuberculosis in Maniema (Zaire)].
    De Caluwe P; Tshalumba MW; Everaerts MC
    Ann Soc Belg Med Trop; 1989 Mar; 69(1):67-73. PubMed ID: 2730174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 8. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
    Nagaraja C; Shashibhushan BL; Asif M; Manjunath PH; Sagar C
    Indian J Chest Dis Allied Sci; 2012; 54(1):23-6. PubMed ID: 22779119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
    Demissie M; Gebeyehu M; Berhane Y
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):64-7. PubMed ID: 9441061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 11. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
    Bercion R; Kuaban C
    Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.
    Hongthiamthong P; Chuchottaworn C; Amatayakul N
    J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High initial drug resistance in pulmonary tuberculosis in Ghana.
    van der Werf TS; Groothuis DG; van Klingeren B
    Tubercle; 1989 Dec; 70(4):249-55. PubMed ID: 2516670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis.
    Lancet; 1981 Jan; 1(8213):171-4. PubMed ID: 6109855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis].
    Gómez Marín JE; Rigouts L; Villegas Londoño LE; Portaels F
    Bol Oficina Sanit Panam; 1995 Jul; 119(1):1-10. PubMed ID: 7654295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.